CLASS II ONGOING Device recall · Reported 19 Jun 2024 · FDA Enforcement Report

Codman Bactiseal Evd Catheter Set - Indicated recalled

Integra LifeSciences is recalling Codman Bactiseal Evd Catheter Set - Indicated for gaining access to the ventricles of the, distributed nationwide in the US. The recall was initiated on 7 May 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 10381780515593 Lot numbers: 7320001, 7320004, 720005, 7322926, 322927
Quantity recalled135 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2136-2024
FDA event ID
94622
Recalling firm
Integra LifeSciences, Princeton, NJ
Classification
Class II
Status
Ongoing
Recall initiated
7 May 2024
FDA classified
12 Jun 2024
Reported
19 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Sterility

Timeline

7 May 2024Recall initiated by company
12 Jun 2024Classified by FDA+36 days
19 Jun 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defect in the external sterile packaging (pouch) leading to a gap or/and weakness of the seal that may compromise the product sterility.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

CODMAN BACTISEAL EVD Catheter Set - Indicated for gaining access to the ventricles of the brain and can be used with dimensionally compatible devices for draining cerebrospinal fluid (CSF) and other fluids of similar physical characteristics as a means of reducing intracranial pressure and CSF volume. Product Number: 821745

Where it was distributed

Worldwide - US Nationwide distribution in the state of TX and the countries of Canada, China, Croatia, Hungary, Russia, Singapore, Slovenia, South Africa, Taiwan (Province of China), Turkey

Nationwide Texas

Questions about this recall

Why was it recalled?

Defect in the external sterile packaging (pouch) leading to a gap or/and weakness of the seal that may compromise the product sterility.

Which lots are affected?

UDI-DI: 10381780515593 Lot numbers: 7320001, 7320004, 720005, 7322926, 322927

Where was it sold?

Worldwide - US Nationwide distribution in the state of TX and the countries of Canada, China, Croatia, Hungary, Russia, Singapore, Slovenia, South Africa, Taiwan (Province of China), Turkey

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 94622

More recalls from Integra LifeSciences

All 246

Other Heart & Vascular Devices recalls

All 6,199